We are live on ! Find out more
LABS

Direxion Daily S&P Biotech Bear 1X Shares
LABS

Delisted

LABS was delisted on the 25th of September, 2017.

Back to rankings

1 hedge funds and large institutions have $1.46M invested in Direxion Daily S&P Biotech Bear 1X Shares in 2016 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% less capital invested

Capital invested by funds: $2.15M → $1.46M (-$695K)

50% less funds holding

Funds holding: 2 → 1 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$264K
2
VF
Virtu Financial
New York
-$61.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$1.46M -$61.6K -1,536 -4%
Jane Street
2
Jane Street
New York
– -$264K -5,608 Closed

LABS Hedge Fund Activity: Q3 2016 in Review

1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 1X Shares (LABS) for Q3 2016, worth a combined $1.46M — down 32% from $2.15M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of LABS and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Jane Street, exiting entirely with an estimated $264K sold.

  • 1 institutional investor held Direxion Daily S&P Biotech Bear 1X Shares (LABS) as of Q3 2016, down from 2 in Q2 2016.
  • Funds reported $1.46M of Direxion Daily S&P Biotech Bear 1X Shares stock for Q3 2016, down 32% quarter-over-quarter.
  • 0 funds opened new Direxion Daily S&P Biotech Bear 1X Shares positions in Q3 2016 and 1 closed out, a net change of -1 holder.
  • The largest Direxion Daily S&P Biotech Bear 1X Shares seller in Q3 2016 was Jane Street, an estimated $264K sold.

Based on aggregated 13F filings for Q3 2016.